glp 1 agonists canada GLP-1 Market Report 2025-2033, By Product, Molecule, and Geo CPHA: Canada Now Second-Largest GLP-1

Multiple generics of liraglutide (Victoza) are available for the treatment of T2DM

doi: 10.3389/fendo.2021.735019 79 LazzaroniEBen NasrMLoretelliCPastoreIPlebaniLLunatiMEet al

[DOI] [PubMed] [Google Scholar] 257.Mochida T., Hira T., Hara H

If this condition persists chronically, the glucoregulatory mechanism can become dysfunctional, leading to continuous hyperglycemia

In SUSTAIN-6 trial similar effects in MACE risk reduction, glycemic control and hypoglycemia rates were observed in patients receiving 0.5 mg semaglutide once weekly and in those receiving 1 mg once weekly (43)

Summary Foundayo is a GLP-1 receptor agonist, placing it in the same drug class as Ozempic, Wegovy, and Mounjaro, but its small-molecule structure allows it to function as a once-daily pill rather than a weekly injection